Clinical study on the reversal of indolent B cell lymphoma with fuzheng Huatuanjiedu decoctio
Not Applicable
- Conditions
- Inert B cell lymphoma
- Registration Number
- ITMCTR2000003820
- Lead Sponsor
- onghua Hospital affiliated to Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
1. Patients with indolent B-cell lymphoma conforming to the above diagnosis by Traditional Chinese and western medicine do not need to receive western medicine treatment for their condition evaluation;
2. Aged 18 and 80 years old;
3. Sign informed consent.
Exclusion Criteria
1. Patients who meet the diagnostic criteria but are complicated with serious organic diseases such as heart, liver, kidney, brain and other malignant tumors are not eligible for the authors;
2. Those who are allergic to the drugs used, have adverse reactions or are in critical condition;
3. Participants in other clinical trials at the same time.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ferritin;Flow cytometry;Beta 2 microglobulin;LDH;cytokines;
- Secondary Outcome Measures
Name Time Method Routine blood;Liver and kidney function;